哈森股份(603958.SH):擬合計出資1000萬元投資兩個私募基金 涉及醫療健康領域
格隆匯6月22日丨哈森股份(603958.SH)發佈關於投資私募基金的公吿,公司擬通過南京金璧創業投資合夥企業(有限合夥)(“南京金璧基金”)參與投資南京暾智金湧生物醫藥創業投資合夥企業(有限合夥)(“南京暾智金湧基金”),擬以自有資金認繳出資500萬元,間接佔南京暾智金湧基金認繳出資總額的1.67%。
另外,公司擬通過南京金靳創業投資合夥企業(有限合夥)(“南京金靳基金”)參與投資南京金溧創業投資合夥企業(有限合夥)(“南京金溧基金),擬以自有資金認繳出資500萬元,間接佔南京金溧基金認繳出資總額的1.67%。
南京暾智金湧基金專注投資於中國的醫療健康領域,南京金溧基金主要對醫療健康、新材料、高端智能製造行業內的企業進行投資。上述投資有利於公司在投資風險可控的前提下,獲取相關的財務收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.